Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Bordignon

Showing results (21-30 of 96) with videos related to

Pageof 10
Sort By:
Frontiers in Immunology|March 3, 2020
CAR T Cells Redirected to CD44v6 Control Tumor Growth in Lung and Ovary Adenocarcinoma Bearing MiceSimona Porcellini, Claudia Asperti, Stefano Corna, et al.
Emerging Infectious Diseases|April 28, 2004
Coronaviridae and SARS-associated coronavirus strain HSR1Elisa Vicenzi, Filippo Canducci, Debora Pinna, et al.
The Journal of Biological Chemistry|May 16, 2008
Structural basis for the interaction of isoDGR with the RGD-binding site of alphavbeta3 integrinAndrea Spitaleri, Silvia Mari, Flavio Curnis, et al.
Angewandte Chemie (International Ed. in English)|January 9, 2010
2D TR-NOESY experiments interrogate and rank ligand-receptor interactions in living human cancer cellsSilvia Mari, Chiara Invernizzi, Andrea Spitaleri, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2007
Abrogation of prostaglandin E2/EP4 signaling impairs the development of rag1+ lymphoid precursors in the thymus of zebrafish embryosEduardo J Villablanca, Anna Pistocchi, Felipe A Court, et al.
Journal of Biotechnology|May 3, 2005
Expression and purification of a human, soluble Arylsulfatase A for Metachromatic Leukodystrophy enzyme replacement therapySabata Martino, Antonella Consiglio, Cristina Cavalieri, et al.
Frontiers in Immunology|February 6, 2019
Immunomodulatory Drugs in the Context of Autologous Hematopoietic Stem Cell Transplantation Associate With Reduced Pro-tumor T Cell Subsets in Multiple MyelomaGiulia Di Lullo, Magda Marcatti, Silvia Heltai, et al.
Blood|May 16, 2002
Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancerMarco Bregni, Anna Dodero, Jacopo Peccatori, et al.
Cancer Research|September 2, 2008
Isoaspartate-glycine-arginine: a new tumor vasculature-targeting motifFlavio Curnis, Angelina Sacchi, Anna Gasparri, et al.
Blood|January 26, 2008
Altered intracellular and extracellular signaling leads to impaired T-cell functions in ADA-SCID patientsBarbara Cassani, Massimiliano Mirolo, Federica Cattaneo, et al.
Pageof 10

Showing results (21-30 of 96) with videos related to

Sort By:
Pageof 10
Frontiers in Immunology|March 3, 2020
CAR T Cells Redirected to CD44v6 Control Tumor Growth in Lung and Ovary Adenocarcinoma Bearing MiceSimona Porcellini, Claudia Asperti, Stefano Corna, et al.
Emerging Infectious Diseases|April 28, 2004
Coronaviridae and SARS-associated coronavirus strain HSR1Elisa Vicenzi, Filippo Canducci, Debora Pinna, et al.
The Journal of Biological Chemistry|May 16, 2008
Structural basis for the interaction of isoDGR with the RGD-binding site of alphavbeta3 integrinAndrea Spitaleri, Silvia Mari, Flavio Curnis, et al.
Angewandte Chemie (International Ed. in English)|January 9, 2010
2D TR-NOESY experiments interrogate and rank ligand-receptor interactions in living human cancer cellsSilvia Mari, Chiara Invernizzi, Andrea Spitaleri, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2007
Abrogation of prostaglandin E2/EP4 signaling impairs the development of rag1+ lymphoid precursors in the thymus of zebrafish embryosEduardo J Villablanca, Anna Pistocchi, Felipe A Court, et al.
Journal of Biotechnology|May 3, 2005
Expression and purification of a human, soluble Arylsulfatase A for Metachromatic Leukodystrophy enzyme replacement therapySabata Martino, Antonella Consiglio, Cristina Cavalieri, et al.
Frontiers in Immunology|February 6, 2019
Immunomodulatory Drugs in the Context of Autologous Hematopoietic Stem Cell Transplantation Associate With Reduced Pro-tumor T Cell Subsets in Multiple MyelomaGiulia Di Lullo, Magda Marcatti, Silvia Heltai, et al.
Blood|May 16, 2002
Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancerMarco Bregni, Anna Dodero, Jacopo Peccatori, et al.
Cancer Research|September 2, 2008
Isoaspartate-glycine-arginine: a new tumor vasculature-targeting motifFlavio Curnis, Angelina Sacchi, Anna Gasparri, et al.
Blood|January 26, 2008
Altered intracellular and extracellular signaling leads to impaired T-cell functions in ADA-SCID patientsBarbara Cassani, Massimiliano Mirolo, Federica Cattaneo, et al.
Pageof 10